Shares in Shanghai Henlius Biotech, backed by Chinese conglomerate Fosun International, were set to open down 4% at HK$47.45 ($6.05) on their market debut in Hong Kong on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
